Skip to main content

Volume 18 Supplement 1

19th Annual SCMR Scientific Sessions

  • Poster presentation
  • Open access
  • Published:

High-sensitivity Troponin-T levels in reperfused STEMI patients: A comparison with CMR


In reperfused ST-segment elevation myocardial infarction (STEMI), CMR late gadolinium enhancement (LGE) is the gold-standard for quantifying myocardial infarct (MI) size. Serum cardiac biomarker area-under-the-curve (AUC) is also used (CK-MB, Troponin T and I) and is more widely available than CMR. However, whether acute MI size measured by the 5th generation high-sensitivity Troponin T assays (hs-Trop T) correlates with that by LGE-CMR is not known.


Forty-eight patients presenting with an acute STEMI treated by primary angioplasty (PPCI) had CMR and hs-Trop T levels were measured prior to PPCI and at 6, 12 and 24 hours post-PPCI. These 4 time-points were used for the AUC calculation. The assay was a one-step enzyme immunoassay (electro-chemiluminescence based, Elecsys 2010, Roche, Switzerland). Of note, it cannot further quantify elevations >10,000 ng/L. CMR was performed on a 1.5-T scanner 3-6 days after PPCI. Acute MI size was quantified by LGE 10 minutes after gadolinium injection (Otsu method) using ImageJ (National Institutes of Health, Bethesda, Maryland), which was also used for volume and mass. Microvascular obstruction (+/- haemorrhage) was included in the infarct area. Infarction was expressed in gram mass. Pearson's correlation coefficient and Independent Student's t-test were used.


Hs-Trop T AUC showed good correlation (r = 0.64, p < 0.0001) with LGE infarct size, as did 12-hour hs-Trop T (r = 0.63, p < 0.0001). There was an inverse correlation between hs-TropT AUC and LV ejection fraction (r = -0.633, p < 0.0001). Hs-TropT AUC levels were also significantly higher (p < 0.0001) in patients with microvascular obstruction (MVO).


The widely available 5th generation hs-TropT can quantify acute MI size. A single measurement at 12 hours was as good as 24-hour AUC. Elevations in hs-TropT were associated with a lower LV ejection fraction and the presence of MVO.

Figure 1
figure 1

Scatter-plot of hs-TropT AUC (x10,000 ng/L × hour) measurements against MI size (g).

Figure 2
figure 2

Scatter-plot of hs-TropT AUC (x10,000 ng/L × hour) measurements against Ejection Fraction (%).

Author information

Authors and Affiliations


Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramlall, M., White, S.K., Bulluck, H. et al. High-sensitivity Troponin-T levels in reperfused STEMI patients: A comparison with CMR. J Cardiovasc Magn Reson 18 (Suppl 1), P72 (2016).

Download citation

  • Published:

  • DOI: